ArticleActa pharmacologica Sinica2026
A novel CDK8/19 inhibitor RO8323 mitigates allograft rejection through dual mechanisms of action to modulate regulatory T cell and myeloid cell.
Fang Shen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.